Delivery Order SPE2DB20D1100-SPE2DB25FC0T8
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,081.74 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of letrozole 2.5 mg tablets, a medication used to treat breast cancer. This is a firm-fixed-price contract with a period of performance through February 4, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,399.73, is for the supply of Letrozole 2.5 mg tablets, a medication used to treat breast cancer. The contract is a firm fixed-price delivery order, with a period of performance through February 6, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award, valued at $1,161.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Letrozole 2.5 mg tablets, a medication used in the treatment of breast cancer. The contract has an ultimate completion date of March 21, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award, valued at $1,219.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Letrozole 2.5 mg tablets, a medication used in the treatment of breast cancer. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count packages of the prescription drug Letrozole 2.5 mg tablets, with a total ceiling value of $4,736.41 and a performance period ending on April 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,661.95, is for the delivery of LETROZOLE 2.5 MG TABLET 90S, a generic medication used to treat breast cancer. The contract has a firm fixed price pricing type and a completion date of November 4, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,064.85 firm fixed-price contract is for the supply of 4,565,708,495 units of Letrozole 2.5 mg Tablets, a medication used to treat certain types of breast cancer. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,612.74, is for the delivery of Letrozole 2.5 mg tablets in 90-count packages. The contract is a Delivery Order type with a Firm Fixed Price pricing mechanism, and has an ultimate completion date of February 14, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,411.05, is for the delivery of Letrozole 2.5 mg tablets in 90-count packages. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of April 14, 2025. This award does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,238.12 firm-fixed-price delivery order contract is for the supply of Letrozole 2.5 mg tablets, a medication used in the treatment of breast cancer. The contract has an ultimate completion date of October 30, 2024 and does not include any set-aside designations, indicating open competition. AmerisourceBergen holds...